Racial bias in recruitment to clinical trials on paediatric asthma

Adam Lawton1, Alexander Stephenson-Allen2, Abigail Whitehouse3

  • 1North Middlesex NHS Hospital Trust, United Kingdom.

Insights

Clinical trials for pediatric asthma lack diversity. White children are overrepresented, while non-white children are underrepresented in asthma research, impacting treatment equity.

Area of Science:

  • Pediatric pulmonology
  • Clinical trial diversity
  • Health equity in childhood asthma

Background:

  • Asthma is the most common chronic childhood illness.
  • Disparities in medical care affect pediatric asthma outcomes.
  • Representation in clinical trials is crucial for equitable treatment.

Purpose of the Study:

  • To assess the ethnic diversity of participants in pediatric asthma clinical trials.
  • To identify the proportion of white and non-white children in asthma research over the last decade.

Main Methods:

  • Searched ClinicalTrials.gov for completed interventional pediatric asthma studies (2011-2021).
  • Analyzed demographic data for race and ethnicity of study participants.
  • Calculated the percentage of white and non-white children in the analyzed trials.

Main Results:

  • Of 112,327 patients across 208 studies, 69% were identified as White/Caucasian.
  • Fewer than 13% of participants were identified as Black/African/African-American.
  • Approximately 30% of study participants, totaling 34,207 children, were from non-white backgrounds.

Conclusions:

  • Significant underrepresentation of non-white children in pediatric asthma clinical trials was observed.
  • Researchers must prioritize representative populations in trial design.
  • Ensuring diversity in clinical trials is essential for equitable asthma treatment and outcomes.

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
494
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Bias01:22

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
4.8K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K